COMPLETEDPhase 2

mHealth for ART Adherence by HIV+ African Americans

The objective of this grant is to create and test a mobile app to support ART adherence among HIV+ African American adults.

Sponsor

Environment and Health Group, Inc.

Enrollment

109 participants

Sites

1 locations

Start Date

April 2019

Completion

May 2020

HIV-1-infectionOn the Dot Mobile app

Enrollment & Timeline

Completed

Target N

109

participants

Sites

locations

Duration

13 months

total trial span

Rate

pts/month needed

At 1 sites, each site needs to enroll approximately 8.0 patients/month to hit the enrollment target on schedule.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

Self-reported ART medication adherence

90 days

Adherence was assessed using a 3-item self-report measure examining ART use in the prior 7 days, a time period, which is considered a reliable indictor of overall adherence (Bianco et al., 2010; Kleeburger et al., 2001; Segeral et al., 2010; Spire et al. 2008). The measure consists of a yes or no response to each of the following three questions: (i) "did you miss any ART doses during the last four days?," (ii) "Were you late for any of your intakes by more than two hours during the last four days?," and (iii) "did you miss any ART doses last week-end?"

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

No linked publications found in PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Fetching protocol from ClinicalTrials.gov…

COMPLETEDPhase 2

mHealth for ART Adherence by HIV+ African Americans

The objective of this grant is to create and test a mobile app to support ART adherence among HIV+ African American adults.

Sponsor

Environment and Health Group, Inc.

Enrollment

109 participants

Sites

1 locations

Start Date

April 2019

Completion

May 2020

HIV-1-infectionOn the Dot Mobile app

Enrollment & Timeline

Completed

Target N

109

participants

Sites

locations

Duration

13 months

total trial span

Rate

pts/month needed

At 1 sites, each site needs to enroll approximately 8.0 patients/month to hit the enrollment target on schedule.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

Self-reported ART medication adherence

90 days

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

No linked publications found in PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Eligibility

Min Age

30 Years

Sex

all

Healthy Volunteers

View full criteria

Inclusion Criteria:

(a) self-identify as African American, (b) age 30 or older, (c) HIV positive (d) currently on ART (e) report having problems with, and interest in improving their ART adherence (f) own a smartphone (g) report English as their primary language

\-

Exclusion Criteria:

(a) not self-identified as African American, (b) under age 30 (c) HIV negative (d) not currently on ART (e) do not report having problems with, or interest in, improving their ART adherence (f) do not own a smartphone (g) do not report English as a primary language and (h) participating in another research study or clinical trial (i) receiving care at non-participating site and, (j) dementia diagnosis.

\-

mHealth for ART Adherence by HIV+ African Americans

Enrollment & Timeline

Primary Outcomes

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

mHealth for ART Adherence by HIV+ African Americans

Enrollment & Timeline

Primary Outcomes

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Eligibility

Trial Sites (1)